Status of Research on Vitamin D Supplementation in Treating or Preventing Liver Fibrosis

Overview

Journal Liver Int

Specialty Gastroenterology

Date 2013 Apr 9

PMID 23560728

Citations 9

Authors

Byoung-Joon Song

Don C Rockey

Affiliations

Soon will be listed here.

Citing Articles

Insulin-sensitizing effects of vitamin D repletion mediated by adipocyte vitamin D receptor: Studies in humans and mice.

Lontchi-Yimagou E, Kang S, Goyal A, Zhang K, You J, Carey M Mol Metab. 2020; 42:101095.

PMID: 33045433 PMC: 7585951. DOI: 10.1016/j.molmet.2020.101095.

Association of seasonality and serum albumin concentration with vitamin D deficiency in subjects with chronic hepatitis C infection living in a sunny country.

Pott-Junior H, Luzeiro C, Senise J, Castelo A Public Health Nutr. 2020; 23(7):1247-1253.

PMID: 32148208 PMC: 10200496. DOI: 10.1017/S1368980019004178.

Effects of vitamin D on insulin resistance and myosteatosis in diet-induced obese mice.

Benetti E, Mastrocola R, Chiazza F, Nigro D, DAntona G, Bordano V PLoS One. 2018; 13(1):e0189707.

PMID: 29342166 PMC: 5771572. DOI: 10.1371/journal.pone.0189707.

Vitamin D Loading Is Superior to Conventional Supplementation After Weight Loss Surgery in Vitamin D-Deficient Morbidly Obese Patients: a Double-Blind Randomized Placebo-Controlled Trial.

Luger M, Kruschitz R, Kienbacher C, Traussnigg S, Langer F, Prager G Obes Surg. 2016; 27(5):1196-1207.

PMID: 27837387 PMC: 5403855. DOI: 10.1007/s11695-016-2437-0.

Effects of Vitamin D Supplementation on Serum 25-Hydroxyvitamin D Concentrations in Cirrhotic Patients: A Randomized Controlled Trial.

Pilz S, Putz-Bankuti C, Gaksch M, Spindelboeck W, Haselberger M, Rainer F Nutrients. 2016; 8(5).

PMID: 27171112 PMC: 4882691. DOI: 10.3390/nu8050278.

References

Fallowfield J . Therapeutic targets in liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2011; 300(5):G709-15. DOI: 10.1152/ajpgi.00451.2010. View

Haussler M, Haussler C, Jurutka P, Thompson P, Hsieh J, Remus L . The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol. 1997; 154 Suppl:S57-73. View

Rosen C, Adams J, Bikle D, Black D, Demay M, Manson J . The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev. 2012; 33(3):456-92. PMC: 3365859. DOI: 10.1210/er.2012-1000. View

Mehal W, Iredale J, Friedman S . Scraping fibrosis: expressway to the core of fibrosis. Nat Med. 2011; 17(5):552-3. PMC: 3219752. DOI: 10.1038/nm0511-552. View

Barchetta I, Carotti S, Labbadia G, Gentilucci U, Onetti Muda A, Angelico F . Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. Hepatology. 2012; 56(6):2180-7. DOI: 10.1002/hep.25930. View

Slominski A, Janjetovic Z, Tuckey R, Nguyen M, Bhattacharya K, Wang J . 20S-hydroxyvitamin D3, noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo. J Clin Endocrinol Metab. 2013; 98(2):E298-303. PMC: 3565109. DOI: 10.1210/jc.2012-3074. View

Nimer A, Mouch A . Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients. World J Gastroenterol. 2012; 18(8):800-5. PMC: 3286143. DOI: 10.3748/wjg.v18.i8.800. View

Charlton M, Krishnan A, Viker K, Sanderson S, Cazanave S, McConico A . Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol. 2011; 301(5):G825-34. PMC: 3220319. DOI: 10.1152/ajpgi.00145.2011. View

Corey K, Zheng H, Mendez-Navarro J, Delgado-Borrego A, Dienstag J, Chung R . Serum vitamin D levels are not predictive of the progression of chronic liver disease in hepatitis C patients with advanced fibrosis. PLoS One. 2012; 7(2):e27144. PMC: 3281016. DOI: 10.1371/journal.pone.0027144. View

10.

Malham M, Jorgensen S, Lauridsen A, Ott P, Glerup H, Dahlerup J . The effect of a single oral megadose of vitamin D provided as either ergocalciferol (D₂) or cholecalciferol (D₃) in alcoholic liver cirrhosis. Eur J Gastroenterol Hepatol. 2011; 24(2):172-8. DOI: 10.1097/MEG.0b013e32834d1755. View

11.

Wynn T, Ramalingam T . Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012; 18(7):1028-40. PMC: 3405917. DOI: 10.1038/nm.2807. View

12.

Rode A, Fourlanos S, Nicoll A . Oral vitamin D replacement is effective in chronic liver disease. Gastroenterol Clin Biol. 2010; 34(11):618-20. DOI: 10.1016/j.gcb.2010.07.009. View

13.

Gao B, Bataller R . Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011; 141(5):1572-85. PMC: 3214974. DOI: 10.1053/j.gastro.2011.09.002. View

14.

Arteh J, Narra S, Nair S . Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci. 2009; 55(9):2624-8. DOI: 10.1007/s10620-009-1069-9. View

15.

Lim L, Chalasani N . Vitamin d deficiency in patients with chronic liver disease and cirrhosis. Curr Gastroenterol Rep. 2011; 14(1):67-73. DOI: 10.1007/s11894-011-0231-7. View

16.

Friedman S . Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 2010; 7(8):425-36. DOI: 10.1038/nrgastro.2010.97. View

17.

Crawford B, Labio E, Strasser S, McCaughan G . Vitamin D replacement for cirrhosis-related bone disease. Nat Clin Pract Gastroenterol Hepatol. 2006; 3(12):689-99. DOI: 10.1038/ncpgasthep0637. View

18.

Potter J, Liu X, Koteish A, Mezey E . 1,25-dihydroxyvitamin D3 and its nuclear receptor repress human α1 (I) collagen expression and type I collagen formation. Liver Int. 2013; 33(5):677-86. PMC: 3707129. DOI: 10.1111/liv.12122. View

19.

Abramovitch S, Dahan-Bachar L, Sharvit E, Weisman Y, Ben Tov A, Brazowski E . Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut. 2011; 60(12):1728-37. DOI: 10.1136/gut.2010.234666. View